A UK life science real estate investment venture between BentallGreenOak and Mission Street is planning to deliver one of the largest innovation hubs in South West England.

The investment venture, created early last year, has bought the 1 Temple Way building in Central Bristol with a plan to develop a 135,000sqft life science real estate facility.

The 1 Temple Way building was originally built in 1974 for the Bristol United Press.

“Our intention is to work collaboratively, diligently and at speed to create a next-generation science building of local, regional and national significance, retaining and attracting innovative companies to Bristol,” said Artem Korolev, founder and CEO of Mission Street.

BentallGreenOak and Mission Street said the joint venture’s total portfolio now includes four projects which will total 500,000sqft once completed, with a significant pipeline of future projects.

Toby Phelps, managing partner at BentallGreenOak, said: “BentallGreenOak is excited to add the 4th project to our growing Life Science portfolio with Mission Street.

“There continues to be a severe shortage of supply of high-quality, purpose-built space for the growing Life Science, Deep Tech, and R&D sectors.“

Marvin Rees, the mayor of Bristol, said: “It’s fantastic to announce a further investment into our city as we continue to grow Bristol’s reputation as a centre for cutting edge research and technology.

“Located within walking distance of the Temple Quarter regeneration area and the University of Bristol’s new Enterprise Campus, this new innovation hub will be a welcome addition to Bristol’s burgeoning tech sector and the wider area as we continue to bring new jobs and investment into our city to benefit all communities.”

To read the latest edition of the latest IPE Real Assets magazine click here.